Skip to main content
Glow Lifetech logo

Glow Lifetech — Investor Relations & Filings

Ticker · GLOW ISIN · CA37989H1091 LEI · 5493000039SP09BBAI87 CSE Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2026-04-07 Annual Report
Country CA Canada
Listing CSE GLOW

About Glow Lifetech

https://glowlifetech.com/

Glow Lifetech is a biotechnology company specializing in ingredient innovation for the nutraceutical and cannabinoid markets. The company supplies cutting-edge, natural active ingredients for functional foods, beverages, supplements, and personal care products. Its core technology is the proprietary MyCell® delivery system, which converts proprietary cannabinoids, vitamins, and botanicals into highly bioavailable, water-soluble liquid formats. This system is engineered to optimize absorption, ensuring dramatically improved bioavailability, faster onset (in as little as 20 minutes), enhanced stability, and a clean, neutral taste profile. Glow offers solutions ranging from foundational water-soluble ingredients and customized blends to fully market-ready products, serving as an innovation partner for companies seeking to launch and scale next-generation natural health products.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Annual Report Classification · 1% confidence The document is titled 'Annual Consolidated Financial Statements' for Glow Lifetech Corp. for the years ended December 31, 2025, and 2024. It includes an independent auditor's report, consolidated statements of financial position, statements of loss and comprehensive loss, and notes to the financial statements. This constitutes a full annual financial report, which is classified as a 10-K (Annual Report) in the provided schema. FY 2025
2026-04-07 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Glow Lifetech Corp. announcing business expansion into new markets (Manitoba and New Brunswick). It does not contain financial statements, audit reports, or specific regulatory filings, but rather serves as a general corporate update regarding operational strategy and market growth. As it does not fit into more specific categories like M&A, dividends, or management changes, it falls under the general regulatory announcement category.
2026-02-03 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Glow Lifetech Corp. announcing a new commercial partnership and product launch on the Mendo Medical Cannabis platform. It does not constitute a formal financial report (10-K, IR), a regulatory filing, or a specific corporate action like a dividend or share issue. As it is a general corporate announcement regarding business operations and strategy, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2026-01-07 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109FV2', which is a standard Canadian regulatory certification form for venture issuers. It serves as an officer's attestation regarding the accuracy of interim filings. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like interim filings), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive data. 9M 2025
2025-11-25 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109FV2', which is a Venture Issuer Basic Certificate. It serves as an officer certification/attestation regarding the review and fair presentation of interim filings. Per the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (like an interim report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or data. 9M 2025
2025-11-25 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled 'MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS' for Glow Lifetech Corp. It covers the three and nine months ended September 30, 2025. This is a standard quarterly management report (MD&A) that provides a detailed narrative explanation of financial results, business trends, and outlook, which aligns perfectly with the definition of the MDA category.
2025-11-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.